Skip to main content
Fig. 3 | Infectious Agents and Cancer

Fig. 3

From: Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B

Fig. 3

Changes in the abnormal ALT rate, virological indices and SWE levels during the follow-up of ETV and TDF treatment. A Changes in the rate of abnormal ALT levels during antiviral treatment with ETV and TDF; B Changes of Log10 HBV DNA levels during antiviral treatment with ETV and TDF; C Changes of HBeAg negative conversion rate during antiviral treatment with ETV and TDF; D Changes of Log10 HBsAg quantification during antiviral treatment with ETV and TDF; E Changes of SWE levels during antiviral treatment with ETV and TDF

Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us